Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
373 studies found for:    Northwestern AND transplant
Show Display Options
Rank Status Study
1 Active, not recruiting Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens
Condition: End Stage Renal Failure With Renal Transplant
Interventions: Drug: Tacrolimus with MMF;   Drug: Group 2: Tacrolimus with Everolimus.
2 Recruiting Belatacept 3 Month Post Transplant Conversion Study
Conditions: Transplant; Failure, Kidney;   EBV
Interventions: Drug: belatacept;   Drug: Tacrolimus;   Drug: MPA
3 Recruiting A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients
Conditions: Type 1 Diabetes;   Severe Hypoglycemic Unawareness
Intervention: Biological: Islet Cell Transplant
4 Recruiting Association of Donor Age With Recipient Outcomes in Kidney Transplant
Condition: Complication of Transplant
Intervention:
5 Completed Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents
Conditions: Liver Transplant Rejection;   Immunosuppression
Interventions: Procedure: Blood Draw - Rapamycin;   Procedure: Blood Draw from Control Subjects;   Procedure: Blood Draw - CyA;   Procedure: Blood Draw - Tacrolimus;   Procedure: Blood Draw - MMF
6 Enrolling by invitation Quality of Life in Pre and Post Renal Transplant in Hispanic and Non-Hispanic Recipients
Condition: Transplant; Failure, Kidney
Intervention:
7 Completed Genetic Predisposition-Chronic Nephrotoxicity From CI-Liver Transplant Recipients-Potential Correlation-Urinary Biomarkers
Condition: Complication of Transplanted Liver
Intervention:
8 Active, not recruiting Correlation of Donor-specific Anti-endothelial Cells
Condition: Living-Donor Kidney Transplants
Intervention:
9 Recruiting Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients
Conditions: Acute Rejection (AR) of Transplanted Kidney;   Chronic Allograft Nephropathy (CAN);   Interstitial Fibrosis (IF);   Tubular Atrophy (TA)
Intervention:
10 Recruiting Stem Cell Transplantation for Stiff Person Syndrome (SPS)
Condition: Stiff Person Syndrome
Intervention: Biological: Autologous Hematopoietic Stem Cell Transplantation
11 Recruiting Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress) Monotherapy Early After Liver Transplantation
Condition: Liver Transplantation
Intervention: Drug: Tacrolimus Withdrawal and Everolimus Monotherapy
12 Terminated Prediction of Hepatitis C Recurrence in Liver Transplant Recipients
Conditions: Complication of Transplanted Liver;   Hepatitis C, Chronic
Intervention:
13 Active, not recruiting Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients
Condition: End Stage Renal Disease
Intervention: Drug: Expanded Tregs
14 Completed Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Sorafenib;   Drug: Yttrium-90 (Y-90)
15 Active, not recruiting HLA-Identical Sibling Renal Transplant Tolerance
Conditions: Immunosuppression;   Kidney Transplantation;   Graft Rejection
Intervention: Biological: Infusion of Donor Hematopoietic Stem Cells and Campath-1H
16 Terminated
Has Results
A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression
Condition: Kidney Transplant Failure and Rejection
Interventions: Drug: Tacrolimus (TAC);   Drug: Sirolimus;   Drug: Alemtuzumab;   Drug: Mycophenolate mofetil (MMF)
17 Enrolling by invitation Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients
Condition: Influenza
Intervention: Biological: Influenza vaccine
18 Terminated
Has Results
Immunophenotyping of Peripheral T Cells After T Cell Depletion With Alemtuzumab
Condition: Kidney Transplant
Intervention: Drug: Alemtuzumab
19 Recruiting Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Conditions: Liver Transplant;   Hepatitis C;   Chronic Kidney Disease;   Acute Rejection
Intervention:
20 Terminated A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients
Condition: Transplant; Failure, Kidney
Intervention: Drug: Alefacept (ASP0485)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.